Deadline: January 3, 2013
The Leukemia & Lymphoma Society has released a Request for Applications for the New Idea Award, a new grant program designed to support the development of safer and more effective treatment paradigms for patients with hematological malignancies. Specifically, the program represents a concept grant to support academic researchers with innovative therapy ideas that are substantially different from current standard treatments and may advance to clinical testing in the short term. It is anticipated that each project funded through the program will be unique and represent a high-risk, potentially high-reward opportunity.
The goal of this RFA is to evaluate novel concepts that could lead to significant improvements in the clinical outcomes, including quality of life, of patients with hematological malignancies. Grants will support initial exploration of untested but potentially transformative research ideas and treatment approaches. Applicants must succinctly describe the innovative idea/approach and a method for testing it within one year. Upon completion of the one-year grant period, applicants will be evaluated on the extent to which their concept has been substantiated by initial testing, and promising projects may be selected for extended funding.
Up to eight grants of up to $100,000 will be awarded.
Investigators in academic laboratories are eligible to apply. Investigators must demonstrate that their research environment is equipped and suitable for the proposed study. Applicants need not be United States citizens or be associated with a U.S.-based institution. Applicants should hold a Ph.D., M.D., D.V.M., or equivalent degree.
Visit the Leukemia & Lymphoma Society Web site for complete program guidelines and application procedures.
Link to Complete RFP